[NEJM] Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1–Negative Advanced NSCLC

 关闭 求助已关闭
yuanquan 发表于 2026-11-6 17:49:12 | 显示全部楼层 |阅读模式
悬赏10积分

期刊:New England Journal of Medicine

文献作者:Fei Zhou; Xiangjiao Meng; Qingqing Ding; Peng Zhang; Wenhua Liang; Sanxing Guo; Yan Yu; Wenxiu Yao; Yun Fan; Xingxiang Pu; Chunling Liu; Jiuwei Cui; Peng Chen; Hua Zhong; Yongsheng Wang; Zhangzhou Huang; Zhi Xu; Xiaorong Dong; Tienan Yi; Ying Hu; Qiming Wang; Bolin Chen; Hui Wang; Longhua Sun; Lang He; Wei Zheng; Yina Wang; Xiaochen Zhang; Yu Yao; Yongsheng Li; Zhe Yang; Feng Ye; Xia Song; Ming Zhou; Li Yin; Yan Qing; Xiaoping Jin; Junyou Ge; Caicun Zhou

出版日期:--

DOI号:10.1056/nejmoa2611280

下载链接:http://www.nejm.org/doi/pdf/10.1056/NEJMoa2611280

文献链接:https://doi.org/10.1056/nejmoa2611280

当前文献来源于 Massachusetts Medical Society。


备注信息:
全部回复0 显示全部楼层

发表回复

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

VIP会员
  • 发布

  • 回复

  • 积分

    550

返回列表